ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1288

Frailty Is Associated with Higher Risk of Readmission in Patients with Rheumatoid Arthritis

Waqas Tahir1, Yenny Rosli2, Christopher Leung3, K Wysham4, Jiha Lee5, Radjiv Goulabchand6, Una Makris7, Siddharth Singh8 and Namrata Singh9, 1Mayo Clinic, Jacksonville, FL, 2University of Washington, Seattle, WA, 3Georgetown University School of Medicine, Washington, DC, 4VA Puget Sound/University of Washington, Seattle, WA, 5University of Michigan, Ann Arbor, MI, 6University of California San Diego, La Jolla, CA, 7UT Southwestern Medical Center and Dallas VA, Dallas, TX, 8University of California San Diego, San Diego, CA, 9University of Washington, Bellevue, WA

Meeting: ACR Convergence 2023

Keywords: Aging, geriatrics, Mortality, rheumatoid arthritis, risk assessment

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 13, 2023

Title: (1264–1307) RA – Diagnosis, Manifestations, and Outcomes Poster II

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: With the advent of new therapies and increasing life expectancy, there is a rising number of older adults living with rheumatoid arthritis (RA). Patients with RA are at a higher risk for developing frailty1, and frailty in RA has been linked with increased risk of hospitalization2. However, little is known regarding the association between frailty status and a patient’s hospitalization outcomes. Our study investigated whether frailty increases risk for readmission and inpatient mortality in RA patients.

Methods: Using the 2018 Nationwide Readmissions Database, we identified adult patients (age ≥18 years) admitted with a primary or secondary diagnosis of RA (using ICD 10 codes) between January to June 2018. Utilizing validated claim-based Hospital Frailty Score3, patients’ frailty risk score was calculated at the time of index admission and individuals were categorized into frail (score ≥ 5) and non-frail (score < 5) groups. Our primary outcome of interest was risk of readmission following discharge after index hospitalization. Secondary outcomes of interest included inpatient mortality, prolonged length of admission (≥ 7 days), mean days to readmission, and costs of hospitalization. We used descriptive statistics to compare patient demographics, admission characteristics, and hospital characteristics at index hospitalization in frail vs non-frail groups. Multivariable Cox proportional hazard analysis was performed to evaluate the independent effect of frailty on readmission after controlling for age, sex, household income, hospital characteristics (teaching status, capacity, location), and Elixhauser comorbidities index.

Results: 133,187 patients with RA met our inclusion criteria. Of these, 64,131 (48.15%) patients were categorized as frail, and 69,056 (51.85%) patients were non-frail. Frail patients were older, female, predominantly with Medicare coverage, and had higher Elixhauser comorbidity index (Table 1). Frail patients had a higher rate of readmission (56.60%) compared to the non-frail group (30.61%). After readmission, frail patients also had significantly higher inpatient mortality compared to non-frail patients (3.36% vs 0.39%, p < 0.005) and a longer length of stay (7.82% vs 26.24%, p < 0.005) (Table 2). On multivariate analysis, frailty was independently associated with a 9% increased risk of readmissions (adjusted hazard ratio, 1.09; 95% confidence interval, 1.08 – 1.11) (Table 3).

Conclusion: Frailty is associated with a higher risk of readmissions in patients with RA. In addition, frail patients with RA have higher likelihood for poorer outcomes after hospitalization (such as increased inpatient mortality) relative to non-frail patients. These findings are crucial in identifying hospitalized patients with RA who are at a higher risk of worse outcomes. Future studies should explore modifiable factors to mitigate these risks.

References:
1. van Onna M, et al. PMID: 35314796.
2. Hanlon P, et al. PMID: 35292529.
3. Gilbert T, et al. PMID: 29706364
.

Supporting image 1

Baseline patient demographics, hospital characteristics, and comorbidities at time of index hospitalization by frailty status

Supporting image 2

Longitudinal hospital based related outcomes in patients with RA

Supporting image 3

Cox Proportional Hazard Analysis Evaluating Risk of Readmission by Frailty Risk Score


Disclosures: W. Tahir: None; Y. Rosli: None; C. Leung: None; K. Wysham: None; J. Lee: None; R. Goulabchand: None; U. Makris: None; S. Singh: None; N. Singh: None.

To cite this abstract in AMA style:

Tahir W, Rosli Y, Leung C, Wysham K, Lee J, Goulabchand R, Makris U, Singh S, Singh N. Frailty Is Associated with Higher Risk of Readmission in Patients with Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/frailty-is-associated-with-higher-risk-of-readmission-in-patients-with-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/frailty-is-associated-with-higher-risk-of-readmission-in-patients-with-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology